Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction.

Merkatz RB, Plagianos M, Hoskin E, Cooney M, Hewett PC, Mensch BS.

Contraception. 2014 Nov;90(5):514-21. doi: 10.1016/j.contraception.2014.05.015. Epub 2014 Jun 2.

2.

Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.

Archer DF, Thomas MA, Conard J, Merkatz RB, Creasy GW, Roberts K, Plagianos M, Blithe D, Sitruk-Ware R.

Contraception. 2016 Jan;93(1):58-64. doi: 10.1016/j.contraception.2015.09.008. Epub 2015 Sep 25.

PMID:
26408374
3.

Increased impact of a contraceptive vaginal ring with ethinyl estradiol and nestorone on C-reactive protein.

Rad M, Burggraaf J, Sitruk-Ware RL, de Kam ML, Cohen AF, Kluft C.

Steroids. 2012 Nov;77(13):1483-6. doi: 10.1016/j.steroids.2012.08.003. Epub 2012 Sep 8.

PMID:
22982353
4.

Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.

Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR Jr, Apter D, Gale J, Sivin I, Tsong YY, Fraser IS.

Contraception. 2005 Jul;72(1):46-52.

PMID:
15964292
5.

Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.

Sitruk-Ware RL, Menard J, Rad M, Burggraaf J, de Kam ML, Tokay BA, Sivin I, Kluft C.

Contraception. 2007 Jun;75(6):430-7. Epub 2007 Mar 26.

PMID:
17519148
6.
7.

Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.

Weisberg E, Fraser IS, Lacarra M, Mishell DR Jr, Alvarez F, Brache V, Nash HA.

Contraception. 1999 May;59(5):311-8.

PMID:
10494485
8.

A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.

Weisberg E, Fraser IS, Mishell DR Jr, Lacarra M, Darney P, Jackanicz TM.

Contraception. 1999 May;59(5):305-10.

PMID:
10494484
9.

Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.

Rad M, Kluft C, Ménard J, Burggraaf J, de Kam ML, Meijer P, Sivin I, Sitruk-Ware RL.

Am J Obstet Gynecol. 2006 Jul;195(1):72-7. Epub 2006 Mar 20.

PMID:
16545330
10.

Vaginal ring contraception.

Kerns J, Darney P.

Contraception. 2011 Feb;83(2):107-15. doi: 10.1016/j.contraception.2010.07.008. Epub 2010 Oct 6. Review.

PMID:
21237335
11.

Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.

Weisberg E, Merki-Feld GS, McGeechan K, Fraser IS.

Contraception. 2015 Feb;91(2):121-6. doi: 10.1016/j.contraception.2014.10.006. Epub 2014 Oct 22.

PMID:
25459098
12.

Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.

Kirkman RJ, Bromham DR, O'Connor TP, Sahota JE.

Br J Fam Plann. 1999 Jul;25(2):36-40.

PMID:
10454652
13.

The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.

Novák A, de la Loge C, Abetz L, van der Meulen EA.

Contraception. 2003 Mar;67(3):187-94.

PMID:
12618252
15.

Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring.

Weisberg E, Fraser IS, Lacarra M, Mishell DR Jr, Jackanicz T.

Contraception. 1997 Oct;56(4):233-9.

PMID:
9408704
16.

Factors associated with willingness to use the contraceptive vaginal ring.

Gilliam M, Holmquist S, Berlin A.

Contraception. 2007 Jul;76(1):30-4. Epub 2007 May 24.

PMID:
17586133
17.
18.

Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial.

Roth MY, Shih G, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Sitruk-Ware R, Blithe DL, Amory JK.

Contraception. 2014 Oct;90(4):407-12. doi: 10.1016/j.contraception.2014.05.013. Epub 2014 Jun 2.

19.

High acceptability and satisfaction with NuvaRing use.

Szarewski A.

Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 2:31-6; discussion 37-9. Review.

PMID:
12659400
20.

The hormonal ring: a new contraceptive gains acceptance.

[No authors listed]

Asian Pac Popul Programme News. 1984 Dec;13(4):39-40.

PMID:
12313703

Supplemental Content

Support Center